These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Approach to the use of antimicrobial combinations. Saag MS Ala J Med Sci; 1985 Jan; 22(1):72-5. PubMed ID: 3883831 [No Abstract] [Full Text] [Related]
26. Effects of topical antimicrobial agents on the human neutrophil respiratory burst. Hansbrough JF; Zapata-Sirvent RL; Cooper ML Arch Surg; 1991 May; 126(5):603-8. PubMed ID: 1850590 [TBL] [Abstract][Full Text] [Related]
27. [Interactions between antibacterial drugs]. Witkowska M; Prandota J Postepy Hig Med Dosw; 1976; 30(5):561-77. PubMed ID: 1019051 [No Abstract] [Full Text] [Related]
28. [The use of antibiotic combinations]. Solberg CO Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1405-7. PubMed ID: 4751617 [No Abstract] [Full Text] [Related]
29. [Effects of topical agents for burns on Acinetobacter baumannii within biofilm]. Huang XQ; Xiang J; Song F; Huan JN Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):106-10. PubMed ID: 22781321 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. Kjolseth D; Frank JM; Barker JH; Anderson GL; Rosenthal AI; Acland RD; Schuschke D; Campbell FR; Tobin GR; Weiner LJ J Am Coll Surg; 1994 Sep; 179(3):305-12. PubMed ID: 7520807 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. Heggers JP; Robson MC; Herndon DN; Desai MH J Burn Care Rehabil; 1989; 10(6):508-11. PubMed ID: 2600098 [TBL] [Abstract][Full Text] [Related]
32. Synergy and antagonism of combinations with quinolones. Neu HC Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):255-61. PubMed ID: 1864285 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine. Trott DJ; Moss SM; See AM; Rees R Aust Vet J; 2007 Nov; 85(11):464-6. PubMed ID: 17970852 [No Abstract] [Full Text] [Related]
35. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. Allan JD; Moellering RC Rev Infect Dis; 1985; 7 Suppl 4():S559-71. PubMed ID: 3909313 [TBL] [Abstract][Full Text] [Related]
36. In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patients. Hajská M; Slobodníková L; Hupková H; Koller J Burns; 2014 Jun; 40(4):713-8. PubMed ID: 24091332 [TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection. Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547 [TBL] [Abstract][Full Text] [Related]
38. Antibiotic prophylaxis and therapy in burns. Gillett AP J Hosp Infect; 1985 Sep; 6 Suppl B():59-66. PubMed ID: 2865312 [No Abstract] [Full Text] [Related]
39. Effects of local corticosteroids in skin infections. Raab W Dermatologica; 1976; 152 Suppl 1():67-79. PubMed ID: 955239 [TBL] [Abstract][Full Text] [Related]
40. Control of burn wound sepsis: a comparison of in vitro topical antimicrobial assays. Heggers JP; Velanovich V; Robson MC; Zoellner SM; Schileru R; Boertman J; Niu XT J Trauma; 1987 Feb; 27(2):176-9. PubMed ID: 3493351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]